The Iron Regulatory Peptide Hepcidin Is Expressed in the Heart and Regulated by Hypoxia and Inflammation
The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
The peptide hormone hepcidin plays a central role in iron homeostasis. It is predominantly expressed in the liver and regulated by iron, hypoxia, and inflammation. Although it has been shown that iron plays a key pathophysiological role in cardiac diseases, including iron-overload cardiomyopathy, myocardial ischemia-reperfusion injury, and atherosclerosis, very little is known about the putative expression and the role of hepcidin in the heart. In the present study, expression and regulation of hepcidin in rat heart were analyzed. Basal cardiac expression of hepcidin was demonstrated on mRNA and protein level in vivo in a rat model and compared with its regulation in the liver. The cellular localization was analyzed by immunofluorescence microscopy. Sixteen hours after a single injection of turpentine, a more than 2-fold increase of cardiac hepcidin mRNA and a more than 3-fold increase of hepatic hepcidin mRNA was observed. In response to hypoxia, expression of hepcidin in the liver decreased. In contrast, hypoxia resulted in a strong up-regulation of hepcidin expression on mRNA and protein level in the heart, accompanied by an increased immunoreactivity of hepcidin pronounced at the myocardial intercalated disc area. The finding of a regulated expression of the iron-regulatory peptide hormone hepcidin in the heart suggests that hepcidin may have an important role in cardiac diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Hepcidin is also produced in response to inflammation or other signals by heart cardiomyocytes (Merle et al., 2007) and by brain astrocytes and microglia (Urrutia et al., 2013).”
From Pharmacological Targeting of the Hepcidin/Ferroportin Axis (2016) · cites this paper as Merle et al., 2007
The cited source says what the claim attributes to it.
In the citing paper
“Besides the liver, an increasing number of studies showed that hepcidin is also expressed in other tissues (7–10).”
From Epidermal hepcidin is required for neutrophil response to bacterial infection (2019) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization
Nemeth, E., Tuttle, M. S., Powelson, J., Vaughn, M. B., Donovan, A., Ward, D. M., Ganz, T., & Kaplan, J. (2004) · Science · doi:10.1126/science.1104742 · Cited by 4,803
Cloning and characterization of a mammalian proton-coupled metal-ion transporter
Gunshin, H., Mackenzie, B., Berger, U. V., Gunshin, Y., Romero, M. F., Boron, W. F., Nussberger, S., Gollan, J. L., & Hediger, M. A. (1997) · Nature · doi:10.1038/41343 · Cited by 3,166
Pigeon, C., Ilyin, G., Courselaud, B., Leroyer, P., Turlin, B., Brissot, P., & Loréal, O. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008923200 · Cited by 1,697
Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein
Nemeth, E., Valore, E. V., Territo, M., Schiller, G., Lichtenstein, A., & Ganz, T. (2003) · Blood · doi:10.1182/blood-2002-10-3235 · Cited by 1,417
Nicolas, G., Chauvet, C., Viatte, L., Danan, J. L., Bigard, X., Devaux, I., Beaumont, C., Kahn, A., & Vaulont, S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215686 · Cited by 1,214
Regulation of ferritin genes and protein
Torti, F. M., & Torti, S. V. (2002) · Blood · doi:10.1182/blood.v99.10.3505 · Cited by 1,173
Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene
Fleming, M. D., Trenor, C. C., Su, M. A., Foernzler, D., Beier, D. R., Dietrich, W. F., & Andrews, N. C. (1997) · Nature Genetics · doi:10.1038/ng0897-383 · Cited by 1,159
Ferritin: a cytoprotective antioxidant strategem of endothelium.
Balla, G., Jacob, H. S., Balla, J., Rosenberg, M., Nath, K., Apple, F., Eaton, J. W., & Vercellotti, G. M. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)37165-0 · Cited by 1,097
Hereditary Hemochromatosis — A New Look at an Old Disease
Pietrangelo, A. (2004) · New England Journal of Medicine · doi:10.1056/nejmra031573 · Cited by 992
Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis
Roetto, A., Papanikolaou, G., Politou, M., Alberti, F., Girelli, D., Christakis, J., Loukopoulos, D., & Camaschella, C. (2003) · Nature Genetics · doi:10.1038/ng1053 · Cited by 860
Cited by
Lopez, A., Cacoub, P., Macdougall, I. C., & Peyrin-Biroulet, L. (2016) · The Lancet · doi:10.1016/s0140-6736(15)60865-0 · Cited by 1,492
Iron deficiency: an ominous sign in patients with systolic chronic heart failure
Jankowska, E. A., Rozentryt, P., Witkowska, A., Nowak, J., Hartmann, O., Ponikowska, B., Borodulin-Nadzieja, L., Banasiak, W., Polonski, L., Filippatos, G., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq158 · Cited by 652
Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives
Jankowska, E. A., von Haehling, S., Anker, S. D., Macdougall, I. C., & Ponikowski, P. (2013) · European Heart Journal · doi:10.1093/eurheartj/ehs224 · Cited by 399
“Recently, Maeder et al.120 demonstrated reduced iron content and reduced TfR 1 expression in failing human myocardium when compared with normal hearts.”
BackgroundInfluentialGujja, P., Rosing, D. R., Tripodi, D. J., & Shizukuda, Y. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.03.083 · Cited by 327
Hepcidin: from discovery to differential diagnosis
Kemna, E. H. J. M., Tjalsma, H., Willems, H. L., & Swinkels, D. W. (2008) · Haematologica · doi:10.3324/haematol.11705 · Cited by 313
“Besides this systemic liver hepcidin controlled reduction of iron uptake and release, there is also evidence for local production of hepcidin by macrophages,(27) fat cells(28) and cardiomyocytes.(29) These findings suggest hepcidin is involved in different regulatory mechanisms to control iron imbalance.”
Hepcidin in Human Iron Disorders: Diagnostic Implications
Kroot, J. J., Tjalsma, H., Fleming, R. E., & Swinkels, D. W. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2009.140053 · Cited by 246
Lawen, A., & Lane, D. J. R. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4271 · Cited by 217
“Hepcidin (also known as LEAP-1) is a small peptide that is predominantly produced by hepatocytes in the liver (198, 288), but also at lower levels by the kidney (200) and possibly by the heart (249).”
Anemia and iron deficiency in heart failure: mechanisms and therapeutic approaches
van Veldhuisen, D. J., Anker, S. D., Ponikowski, P., & Macdougall, I. C. (2011) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2011.77 · Cited by 210
“Although the small peptide hormone hepcidin is generally recognized to be important in iron regulation in HF, the exact mechanism of action is still not fully elucidated”
BackgroundHepcidin Regulation of Iron Transport
Collins, J. F., Wessling-Resnick, M., & Knutson, M. D. (2008) · The Journal of Nutrition · doi:10.3945/jn.108.096347 · Cited by 197
“Although production by the liver most likely accounts for the majority of hepcidin in the systemic circulation, the regulatory peptide can be synthesized in other tissues including heart (31,32), kidney (33), adipose tissue (34), spinal cord (35), myeloid cells (36), splenic and alveolar macrophages (37), and monocyte…”
BackgroundOut of Balance—Systemic Iron Homeostasis in Iron-Related Disorders
Steinbicker, A., & Muckenthaler, M. (2013) · Nutrients · doi:10.3390/nu5083034 · Cited by 195
“Other cell types and organs, such as monocytes [14], macrophages [15], heart [16], kidney [17], brain [18], and adipose tissue [19], also produce hepcidin, albeit to much lesser extent.”
BackgroundAn essential cell-autonomous role for hepcidin in cardiac iron homeostasis
Lakhal-Littleton, S., Wolna, M., Chung, Y. J., Christian, H. C., Heather, L. C., Brescia, M., Ball, V., Diaz, R., Santos, A., Biggs, D., et al. (2016) · eLife · doi:10.7554/elife.19804 · Cited by 184
“Other than the liver, hepcidin is also found in tissues with no recognized role in systemic iron homeostasis, including the heart (Merle et al., 2007), the brain (McCarthy and Kosman, 2014), the kidney (Kulaksiz, 2005) and the placenta (Evans et al., 2011).”
BackgroundIron Homeostasis Disorder and Alzheimer’s Disease
Peng, Y., Chang, X., & Lang, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212442 · Cited by 153
Pharmacological Targeting of the Hepcidin/Ferroportin Axis
Sebastiani, G., Wilkinson, N., & Pantopoulos, K. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00160 · Cited by 127
“Hepcidin is also produced in response to inflammation or other signals by heart cardiomyocytes (Merle et al., 2007) and by brain astrocytes and microglia (Urrutia et al., 2013).”
BackgroundSchwartz, A. J., Goyert, J. W., Solanki, S. A., Kerk, S. A., Chen, B., Castillo, C., Hsu, P. P., Do, B. T., Singhal, R., Dame, M. K., et al. (2021) · Nature Metabolism · doi:10.1038/s42255-021-00406-7 · Cited by 151
Pancreatic β-cells express hepcidin, an iron-uptake regulatory peptide
Kulaksiz, H., Fein, E., Redecker, P., Stremmel, W., Adler, G., & Cetin, Y. (2008) · Journal of Endocrinology · doi:10.1677/joe-07-0528 · Cited by 129
Self-citationThe Pathogenesis of Cardiomyopathy in Friedreich Ataxia
Koeppen, A. H., Ramirez, R. L., Becker, A. B., Bjork, S. T., Levi, S., Santambrogio, P., Parsons, P. J., Kruger, P. C., Yang, K. X., Feustel, P. J., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0116396 · Cited by 124
“The protein is also present in non-hepatic tissues, including heart [25] and inflammatory cells [26].”
The Liver in Regulation of Iron Homeostasis
Rishi, G., & Subramaniam, V. N. (2017) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00004.2017 · Cited by 124
“Although there have been reports of local hepcidin production in various other tissues and organs, including the heart (54), alveolar macrophages (60), and splenic macrophages (52), hepatic hepcidin is thought to be the major contributor to systemic regulation of iron.”
BackgroundMethodAdlbrecht, C., Kommata, S., Hulsmann, M., Szekeres, T., Bieglmayer, C., Strunk, G., Karanikas, G., Berger, R., Mortl, D., Kletter, K., et al. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn359 · Cited by 99
“In the first model including hepcidin and the heart, Merle et al.33 found an up-regulation of hepcidin in the heart by hypoxia but at the same time a down-regulation was present in the liver.”
MethodHepcidin modulation in human diseases: From research to clinic
Piperno, A., Mariani, R., Trombini, P., & Girelli, D. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.538 · Cited by 116
Wang, Q., Du, F., Qian, Z.-M., Ge, X. H., Zhu, L., Yung, W. H., Yang, L., & Ke, Y. (2008) · Endocrinology · doi:10.1210/en.2007-1626 · Cited by 114
Iron and Neurodegeneration: Is Ferritinophagy the Link?
Biasiotto, G., Lorenzo, D. D., Archetti, S., & Zanella, I. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9473-y · Cited by 109
“However, experimental evidence has demonstrated the expression of this peptide by several other cells, such as cardiomyocytes [10], pancreatic β-cells [11] and adipocytes [12], where it was shown to act as an autocrine/ paracrine hormone, involved in the local regulation of cellular iron.”
BackgroundAnaemia, iron deficiency and susceptibility to infections
Jonker, F. A. M., & van Hensbroek, M. B. (2014) · Journal of Infection · doi:10.1016/j.jinf.2014.08.007 · Cited by 127
The iron-regulatory hormone hepcidin: A possible therapeutic target?
Rochette, L., Gudjoncik, A., Guénancia, C., Zeller, M., Cottin, Y., & Vergely, C. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.09.004 · Cited by 117
Mu, Y., Huo, J., Guan, Y., Fan, D., Xiao, X., Wei, J., Li, Q., Mu, P., Ao, J., & Chen, X. (2018) · Communications Biology · doi:10.1038/s42003-018-0207-3 · Cited by 106
Gnana-Prakasam, J. P., Martin, P. M., Mysona, B. A., Roon, P., Smith, S. B., & Ganapathy, V. (2008) · Biochemical Journal · doi:10.1042/bj20071377 · Cited by 89
New insights into the links between hypoxia and iron homeostasis
Renassia, C., & Peyssonnaux, C. (2019) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000494 · Cited by 100
Targeted disruption of hepcidin in the liver recapitulates the hemochromatotic phenotype
Zumerle, S., Mathieu, J. R. R., Delga, S., Heinis, M., Viatte, L., Vaulont, S., & Peyssonnaux, C. (2014) · Blood · doi:10.1182/blood-2014-01-550467 · Cited by 87
Schwarz, P., Kübler, J. A. M., Strnad, P., Müller, K., Barth, T. F. E., Gerloff, A., Feick, P., Peyssonnaux, C., Vaulont, S., Adler, G., et al. (2012) · Gut · doi:10.1136/gut.2011.241208 · Cited by 88
“For example, cardiac hepcidin expression was previously shown to be regulated independently from hepatic expression.(9) The unique regulation of gastric hepcidin in response to local stimuli such as pH shift or H pylori infection suggests that it may serve local rather than systemic functions.”
BackgroundMethodSelf-citationIron and the heart: A paradigm shift from systemic to cardiomyocyte abnormalities
Paterek, A., Mackiewicz, U., & Ma̧czewski, M. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28820 · Cited by 91
“A higher concentration of hepcidin results in an elevated ferritin concentration, in hypoxic conditions this mechanism can protect cells from the free radical formation (Merle et al., 2007).”
BackgroundGlucose acts as a regulator of serum iron by increasing serum hepcidin concentrations
Aigner, E. S., Felder, T. K., Oberkofler, H., Hahne, P., Auer, S., Soyal, S. M., Stadlmayr, A., Schwenoha, K., Pirich, C., Hengster, P., et al. (2012) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2012.02.017 · Cited by 84
“Although the liver is the dominant source of circulating hepcidin, extrahepatic sites of hepcidin expression including the obese adipose tissue, alveolar and splenic macrophages, the heart and pancreatic βcells have been identified [14–17].”
BackgroundLipiński, P., Styś, A., & Starzyński, R. R. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1018-1 · Cited by 85
“activated neutrophils and macrophages [3–7].”
Iron metabolism: State of the art
Daher, R., & Karim, Z. (2017) · Transfusion Clinique et Biologique · doi:10.1016/j.tracli.2017.06.015 · Cited by 80
Chen, Q., Wang, L., Ma, Y., Wu, X., Jin, L., & Yu, F. (2013) · Thoracic Cancer · doi:10.1111/1759-7714.12046 · Cited by 75
Adverse Outcome Prediction of Iron Deficiency in Patients with Acute Coronary Syndrome
Zeller, T., Waldeyer, C., Ojeda, F., Schnabel, R. B., Schäfer, S., Altay, A., Lackner, K. J., Anker, S. D., Westermann, D., Blankenberg, S., et al. (2018) · Biomolecules · doi:10.3390/biom8030060 · Cited by 69
“This was also shown in a rat model of hypoxia and a rat model of myocardial infarction, resulting in a strong upregulation of hepcidin expression on messenger RNA (mRNA) and protein levels [22,23].”
BackgroundHamano, H., Ikeda, Y., Watanabe, H., Horinouchi, Y., Izawa‐Ishizawa, Y., Imanishi, M., Zamami, Y., Takechi, K., Miyamoto, L., Ishizawa, K., et al. (2017) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfx252 · Cited by 65
“In addition, hepcidin expression has been observed in not only the liver, but also in the heart [44], kidney [45], brain [46] and spleen [47].”
BackgroundHepcidin: A novel peptide hormone regulating iron metabolism
Singh, B., Arora, S., Agrawal, P., & Gupta, S. K. (2011) · Clinica Chimica Acta · doi:10.1016/j.cca.2011.02.014 · Cited by 61
Isoda, M., Hanawa, H., Watanabe, R., Yoshida, T., Toba, K., Yoshida, K., Kojima, M., Otaki, K., Hao, K., Ding, L., et al. (2009) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2009.04.009 · Cited by 71
Simonis, G., Mueller, K., Schwarz, P., Wiedemann, S., Adler, G., Strasser, R. H., & Kulaksiz, H. (2010) · Peptides · doi:10.1016/j.peptides.2010.05.013 · Cited by 67
Self-citationEpidermal hepcidin is required for neutrophil response to bacterial infection
Malerba, M., Louis, S., Cuvellier, S., Shambat, S. M., Hua, C., Gomart, C., Fouet, A., Ortonne, N., Decousser, J.-W., Zinkernagel, A. S., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci126645 · Cited by 55
“Besides the liver, an increasing number of studies showed that hepcidin is also expressed in 20 other tissues (7-10).”
BackgroundHepcidin: another culprit for complications in patients with chronic kidney disease?
Nakanishi, T., Hasuike, Y., Otaki, Y., Kida, A., Nonoguchi, H., & Kuragano, T. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr410 · Cited by 58
“In addition to being produced by the liver, hepcidin is believed to be produced by macrophages [26], fat cells [27] and the heart [28].”
BackgroundGe, X., Wang, Q. L., Qian, Z., Zhu, L., Du, F., Yung, W., Yang, L., & Ke, Y. (2008) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2008.07.014 · Cited by 54
“014 deleterious effects in humans [1].”
BackgroundInfluentialMolecular Changes in Myocardium in the Course of Anemia or Iron Deficiency
Jankowska, E. A., & Ponikowski, P. P. (2010) · Heart Failure Clinics · doi:10.1016/j.hfc.2010.03.003 · Cited by 56
Structural and functional abnormalities in iron-depleted heart
Kobak, K. A., Radwańska, M., Dzięgała, M., Kasztura, M., Josiak, K., Banasiak, W., Ponikowski, P. P., & Jankowska, E. A. (2018) · Heart Failure Reviews · doi:10.1007/s10741-018-9738-4 · Cited by 55
“Surprisingly, hepcidin is also expressed in other tissues, such as heart [37], kidney [38], brain [39] and placenta [40].”
BackgroundInflammation, dysregulated iron metabolism, and cardiovascular disease
Rosenblum, S. L. (2023) · Frontiers in Aging · doi:10.3389/fragi.2023.1124178 · Cited by 61
“Hepcidin is expressed in the rat myocardium within the intercalated disc region and expression is induced by hypoxic and inflammatory conditions (Merle et al., 2007).”
BackgroundKeeping heart homeostasis in check through the balance of iron metabolism
Vela, D. (2019) · Acta Physiologica · doi:10.1111/apha.13324 · Cited by 44
Weidmann, H., Bannasch, J. H., Waldeyer, C., Shrivastava, A., Appelbaum, S., Ojeda, F., Schnabel, R. B., Lackner, K. J., Blankenberg, S., Zeller, T., et al. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.015480 · Cited by 43
“26,27 This in turn decreases apoptosis and enhances cardiomyocyte survival.”
Mokni, M., Hamlaoui, S., Karkouch, I., Amri, M., Marzouki, L., Limam, F., & Aouani, E. (2013) · Europe PMC (PubMed Central) · Cited by 42
Robinson, J. C., Graham, B. B., Rouault, T. A., & Tuder, R. M. (2014) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2014-0021tr · Cited by 45
“whereas hypoxia and iron depletion lead to a decline in hepcidin levels (36, 37).”
BackgroundEffect of hepcidin antagonists on anemia during inflammatory disorders
Sagar, P., Angmo, S., Sandhir, R., Rishi, V., Yadav, H., & Singhal, N. K. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107877 · Cited by 46
Balance of cardiac and systemic hepcidin and its role in heart physiology and pathology
Vela, D. (2017) · Laboratory Investigation · doi:10.1038/labinvest.2017.111 · Cited by 44
Protective effect of resveratrol against lipopolysaccharide-induced oxidative stress in rat brain
Sebaï, H., Gadacha, W., Sani, M., Aouani, E., Ghanem‐Boughanmi, N., & Ben‐Attia, M. (2009) · Brain Injury · doi:10.3109/02699050903379370 · Cited by 40
“Moreover, endotoxemia-induced iron disturbances occurred in several organs such as heart [28], lung [29], liver [30], kidney [31] and pancreas [32].”
BackgroundCardioprotective effect of resveratrol on lipopolysaccharide-induced oxidative stress in rat
Sebaï, H., Sani, M., Aouani, E., & Ghanem‐Boughanmi, N. (2011) · Drug and Chemical Toxicology · doi:10.3109/01480545.2010.494666 · Cited by 40
“In this respect, LPS-induced hepcidin expression was recently demonstrated in the liver (Park et al., 2001), the brain (Wang et al., 2008), and the heart (Merle et al., 2007).”
BackgroundSerum Hepcidin-20 is Elevated during the Acute Phase of Myocardial Infarction
Suzuki, H., Toba, K., Kato, K., Ozawa, T., Tomosugi, N., Higuchi, M., Kusuyama, T., Iso, Y., Kobayashi, N., Yokoyama, S.-I., et al. (2009) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.218.93 · Cited by 36
Tajes, M., Díez‐López, C., Enjuanes, C., Moliner, P., Ferreiro, J. L., Garay, A., Jiménez‐Marrero, S., Yun, S., Sosa, S. G., Alcoberro, L., et al. (2021) · Cell & Bioscience · doi:10.1186/s13578-021-00605-5 · Cited by 38
“Interestingly, the expression of Hamp is up-regulated in iron-deprived environments to secure the intracellular iron content by exerting a negative feed-back on Fpn1 in the cardiomyocytes [40].”
BackgroundResultKartikasari, A. E. R., Roelofs, R., Schaeps, R. M. J., Kemna, E., Peters, W. H. M., Swinkels, D. W., & Tjalsma, H. (2008) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2008.08.004 · Cited by 38
“antibodies are used for immunoblotting approaches [30–34].”
BackgroundMethodIdentification of three mechanistic pathways for iron-deficient heart failure
Packer, M., Anker, S. D., Butler, J., Cleland, J. G. F., Kalra, P. R., Mentz, R. J., & Ponikowski, P. P. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae284 · Cited by 43
“10 128–130 Although the expression of hepcidin within cardiomyocytes is elevated in response to cardiac injury and stress, 31,131–133 these increases disappear and are reversed, as heart failure evolves and progresses.”
BackgroundTriad role of hepcidin, ferroportin, and Nrf2 in cardiac iron metabolism: From health to disease
Jayakumar, D., Narasimhan, K. K. S., & Kalaiselvi, P. (2021) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2021.126882 · Cited by 35
Aksu, D. S., Sağlam, Y. S., Yıldırım, S., & Aksu, T. (2017) · Cellular and Molecular Biology · doi:10.14715/cmb/2017.63.10.5 · Cited by 42
Wang, G., Cao, X., Lai, S., Luo, X., Feng, Y., Xia, X., Yen, P. M., Gong, J., & Hu, J. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0920 · Cited by 33
“In eukaryotes, both DNA leading strand replication and completion of Okazaki fragments synthesis require PCNA and DNA polymerases such as Pola, Pold, and Pole (19, 23, 24).”
BackgroundNagula, P., Karumuri, S., Otikunta, A. N., & Yerrabandi, S. R. V. (2017) · Indian Heart Journal · doi:10.1016/j.ihj.2017.04.007 · Cited by 31
Anemia and Iron Deficiency in Heart Failure
Arora, N. P., & Ghali, J. K. (2014) · Heart Failure Clinics · doi:10.1016/j.hfc.2013.11.002 · Cited by 34
Daniłowicz‐Szymanowicz, L., Świątczak, M., Sikorska, K., Starzyński, R. R., Raczak, A., & Lipiński, P. (2021) · Diagnostics · doi:10.3390/diagnostics11071279 · Cited by 34
“Hepc expr ssion has also been reported in many other mammalian cells, including cardiomyocytes [54].”
BackgroundStudy of Serum Hepcidin in Hereditary Hemolytic Anemias
El-Beshlawy, A. M., Alaraby, I., Kader, M. S. E. M. A., Ahmed, D. H., & Abdelrahman, H. E. M. (2012) · Hemoglobin · doi:10.3109/03630269.2012.721151 · Cited by 33
“Thus, hepcidin is involved in different regulatory mechanisms that control iron imbalance (6).”
BackgroundPerez, E., Baker, J. R., Giandomenico, S. D., Kermani, P., Parker, J., Kim, K., Yang, J., Barnes, P. J., Vaulont, S., Scandura, J. M., et al. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1901284 · Cited by 32
“systemic iron homeostasis, including the heart (21), the brain (22),”
BackgroundSystemic and tumor level iron regulation in men with colorectal cancer: a case control study
Pusatcioglu, C. K., Nemeth, E., Fantuzzi, G., Llor, X., Freels, S. A., Tussing-Humphreys, L. M., Cabay, R. J., Linzmeier, R. M., Ng, D., Clark, J. S., et al. (2014) · Nutrition & Metabolism · doi:10.1186/1743-7075-11-21 · Cited by 35
“Given that few studies have examined the role of extra-hepatic hepcidin in regulating systemic or tissue-level iron metabolism, further investigations are warranted to understand mechanisms related to iron metabolism in colonic tumors [15,37-39].”
BackgroundPetrák, J., Havlenova, T., Krijt, M., Běhounek, M., Franeková, J., Červenka, L., Pluháček, T., Vyoral, D., & Melenovský, V. (2019) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2019.01.010 · Cited by 27
Biomarkers of inflammation and innate immunity in atrophic nonunion fracture
de Seny, D., Cobraiville, G., Leprince, P., Fillet, M., Collin, C., Mathieu, M., Hauzeur, J., Gangji, V., & Malaise, M. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-1019-1 · Cited by 28
Involvement of hepcidin in iron metabolism dysregulation in Gaucher disease
Lefèbvre, T., Reihani, N., Daher, R., de Villemeur, T. B., Belmatoug, N., Rosé, C., Colin, Y., Puy, H., Kim, C. L. V., Franco, M., et al. (2018) · Haematologica · doi:10.3324/haematol.2017.177816 · Cited by 27
Cocco, E., Porrini, V., Derosas, M., Nardi, V., Biasiotto, G., Maccarinelli, F., & Zanella, I. (2013) · Molecular Biology Reports · doi:10.1007/s11033-013-2792-z · Cited by 25
“This occurs through the formation of reactive oxygen species (ROS) resulting from DOX redox-cycling and DOX direct interaction with free reactive iron [1].”
BackgroundInfluentialExtrahepatic hepcidin production: The intriguing outcomes of recent years
Daher, R., Lefèbvre, T., Puy, H., & Karim, Z. (2019) · World Journal of Clinical Cases · doi:10.12998/wjcc.v7.i15.1926 · Cited by 29
Maternal serum levels and placental expression of hepcidin in preeclampsia
Cardaropoli, S., Todros, T., Nuzzo, A. M., & Rolfo, A. (2018) · Pregnancy Hypertension · doi:10.1016/j.preghy.2017.12.008 · Cited by 28
Iron deficiency anemia in heart failure
Arora, N. P., & Ghali, J. K. (2012) · Heart Failure Reviews · doi:10.1007/s10741-012-9342-y · Cited by 31
“Iron regulatory hormone hepcidin is recognized to play an important role in HF patients [46, 47].”
BackgroundHepcidin Expression in Adipose Tissue Increases during Cardiac Surgery
Vokurka, M., Lacinová, Z., Křemen, J., Kopecky, P., Bláha, J., Pelinková, K., Haluzík, M., & Nečas, E. (2010) · Physiological Research · doi:10.33549/physiolres.931759 · Cited by 28
Zeller, T., Altay, A., Waldeyer, C., Appelbaum, S., Ojeda, F., Ruhe, J., Schnabel, R. B., Lackner, K. J., Blankenberg, S., & Karakas, M. (2018) · Biomolecules · doi:10.3390/biom8030043 · Cited by 25
“Interestingly, while hypoxia appears to induce hepcidin in heart tissue, the opposite is the case in the liver, where hepcidin is suppressed during hypoxia [11].”
BackgroundPacker, M., Anker, S. D., Butler, J., Cleland, J. G. F., Kalra, P. R., Mentz, R. J., Ponikowski, P. P., & Talha, K. M. (2024) · European Journal of Heart Failure · doi:10.1002/ejhf.3237 · Cited by 32
“57,58 Systemic hepcidin acts as a hormone whose synthesis and release is suppressed by macrophage or hepatocyte iron deficiency, 1 3 whereas cardiac hepcidin is upregulated by cardiomyocyte injury and inflammation 57–59 and acts in an intracrine manner to interfere with iron efflux, thus promoting…”
BackgroundDzięgała, M., Kasztura, M., Kobak, K. A., Bania, J., Banasiak, W., Ponikowski, P. P., & Jankowska, E. A. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5705 · Cited by 25
“It is worthwhile mentioning that the function of this iron regulatory hormone locally expressed in the heart and skeletal muscle remains to be fully understood (53-55) and in depth research in this field is required.”
High-Altitude Hypoxia Decreases Plasma Erythropoietin Soluble Receptor Concentration in Lowlanders
Vizcardo‐Galindo, G. A., Lèon‐Velarde, F., & Villafuerte, F. C. (2020) · High Altitude Medicine & Biology · doi:10.1089/ham.2019.0118 · Cited by 25
“indicate an elevated inflammatory state in some of the participants (Hartmann et al., 2000; Nicolas et al., 2002; Merle et al., 2007; Imray et al., 2010).”
BackgroundHepcidin Is an Antibacterial, Stress-Inducible Peptide of the Biliary System
Strnad, P., Schwarz, P., Rasenack, M., Kücükoglu, Ö., Habib, R. I., Heuberger, D., Ehehalt, R., Müller, M. W., Stiehl, A., Adler, G., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016454 · Cited by 31
“the liver [2] and to the previously reported HAMP up-regulation during inflammation [11,12,25].”
BackgroundSelf-citationChen, R., Zhang, H., Zhang, H., Zhou, H., Tong, W., Wu, Y., Ma, M., & Chen, Y. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.175729 · Cited by 25
Risk factors and metabolic mechanisms in the pathogenesis of uraemic cardiac disease
Bhandari, S. (2010) · Frontiers in bioscience · doi:10.2741/3794 · Cited by 26
“This leads to increased hepcidin thus affecting the utilization of iron by cells such as the mitochondria (85, 139-141).”
BackgroundIdentification, characterization and expression analysis of hepcidin gene in sheep
Badial, P. R., Oliveira-Filho, J. P., da Cunha, P. H. J., Cagnini, D. Q., Araújo, J. P., Winand, N. J., & Borges, A. S. (2010) · Research in Veterinary Science · doi:10.1016/j.rvsc.2010.07.017 · Cited by 25
“Hepcidin expression in those tissues was lower than in liver (Pigeon et al., 2001; Ilyin et al., 2003; Fry et al., 2004; Chen et al., 2005; Sang et al., 2006; Merle et al., 2007; Wang et al., 2009).”
BackgroundResultIron Pathophysiology in Stroke
Almutairi, M. M., Xu, G., & Shi, H. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-9589-5_6 · Cited by 22
Heart and iron deficiency anaemia in rats with renal insufficiency: The role of hepcidin
Toblli, J. E., Cao, G., Rivas, C., & Kulaksiz, H. (2008) · Nephrology · doi:10.1111/j.1440-1797.2008.01019.x · Cited by 23
“It is predominantly expressed in the liver, but also in kidney and heart.(31,32) Hepcidin synthesis is induced by iron loading and inflammation and suppressed by hypoxia and erythropoietic activity.”
BackgroundSelf-citationSilencing of hepcidin enforces the apoptosis in iron-induced human cardiomyocytes
Hsieh, Y., Huang, C.-H., Lee, C.-Y., Lin, C., & Chang, C. (2014) · Journal of Occupational Medicine and Toxicology · doi:10.1186/1745-6673-9-11 · Cited by 23
Hepcidin: an important iron metabolism regulator in chronic kidney disease
Antunes, S. A., & Canziani, M. E. F. (2016) · Brazilian Journal of Nephrology · doi:10.5935/0101-2800.20160053 · Cited by 30
Cardiac Hepcidin Expression Associates with Injury Independent of Iron
van Breda, G. F., Bongartz, L. G., Zhuang, W., van Swelm, R. P. L., Pertijs, J. C. L. M., Braam, B. G., Cramer, M. J., Swinkels, D. W., Doevendans, P. A., Verhaar, M. C., et al. (2016) · American Journal of Nephrology · doi:10.1159/000449419 · Cited by 21
Mitophagy and iron: two actors sharing the stage in age-associated neuronal pathologies
Schiavi, A., Strappazzon, F., & Ventura, N. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111252 · Cited by 24
Hepcidin and Iron Metabolism in Pregnancy: Correlation with Smoking and Birth Weight and Length
Chełchowska, M., Ambroszkiewicz, J., Gajewska, J., Głąb-Jabłońska, E., Maciejewski, T., & Ołtarzewski, M. (2016) · Biological Trace Element Research · doi:10.1007/s12011-016-0621-7 · Cited by 23
“the iron and inflammation-induced upregulation of hepcidin, which would lead to a relative lowering of hepcidin and elevated iron absorption [11, 39].”
Iron metabolism gene expression in human skeletal muscle
Polonifi, A., Politou, M., Kalotychou, V., Xiromeritis, K., Tsironi, M., Berdoukas, V., Vaiopoulos, G., & Aessopos, A. (2010) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2010.07.002 · Cited by 22
Ruhe, J., Waldeyer, C., Ojeda, F., Altay, A., Schnabel, R. B., Schäfer, S., Lackner, K. J., Blankenberg, S., Zeller, T., & Karakas, M. (2018) · Biomolecules · doi:10.3390/biom8030072 · Cited by 20
“Interestingly, by intravenous iron injection mitochondrial respiratory capacity and inotropic reserve were restored, cardiac iron stores were replenished and adverse remodelling after AMI was attenuated in IRP-deleted mice.”
ResultInfluentialBoero, M., Pagliaro, P., Tullio, F., Pellegrino, R. M., Palmieri, A., Ferbo, L., Saglio, G. N., Gobbi, M. D., Penna, C. R. R., & Roetto, A. (2015) · BioFactors · doi:10.1002/biof.1237 · Cited by 21
“Since Tfr2β resulted to be highly transcribed in heart [5], as well as Hepcidin (Hamp) [8] and Ferroportin 1 (Fpn1) [9] genes, we planned to investigate if Tfr2β isoform could have some role in”
BackgroundCardiac iron metabolism during aging – Role of inflammation and proteolysis
Walter, S., Mertens, C., Muckenthaler, M. U., & Ott, C. (2023) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2023.111869 · Cited by 20
Krijt, M., Jirkovská, A., Kabickova, T., Melenovský, V., Petrák, J., & Vyoral, D. (2018) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2018.09.005 · Cited by 21
Host and microbiota derived extracellular vesicles: Crucial players in iron homeostasis
Daou, Y., Falabrègue, M., Pourzand, C., Peyssonnaux, C., & Edeas, M. A. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.985141 · Cited by 20
“Also, several studies have reported local synthesis of hepcidin by multiple other tissues, notably in disease, like the and the lungs (77), kidney (78), stomach (79), adipose tissue (75), brain (80), heart (81), and even the skin (82).”
BackgroundIn-depth review: is hepcidin a marker for the heart and the kidney?
Afşar, R. E., Kanbay, M., Ibis, A., & Afşar, B. (2021) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-021-04168-4 · Cited by 20
“[8] demonstrated the distinctive expression of hepcidin by hypoxia in the heart.”
BackgroundSaâdi, S., Ghazali, H. M., Saari, N., & Abdulkarim, S. M. (2021) · Biophysical Chemistry · doi:10.1016/j.bpc.2021.106565 · Cited by 17
Ying, H., Shen, Z., Wang, J., & Zhou, B. (2021) · Herz · doi:10.1007/s00059-021-05039-w · Cited by 19
“As a response to hypoxia, the expression of cardiac HAMP is upregulated, while the expression of hepatic HAMP is inhibited because cardiac HAMP may only affect the heart, but hepatic HAMP is involved in iron homeostasis in the whole system [46].”
BackgroundAschi, M., Bozzi, A., Bartolomeo, R. D., & Petruzzelli, R. (2010) · Biopolymers · doi:10.1002/bip.21499 · Cited by 16
Bolotta, A., Abruzzo, P. M., Baldassarro, V. A., Ghezzo, A., Scotlandi, K., Marini, M., & Zucchini, C. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/7623023 · Cited by 15
“Cardiac expression of HAMP is induced in response to hypoxia and inflammation [18].”
Mazgaj, R., Szudzik, M., Lipiński, P., Jończy, A., Smuda, E., Kamyczek, M., Cieślak, B., Swinkels, D. W., Lenartowicz, M., & Starzyński, R. R. (2020) · Animals · doi:10.3390/ani10071113 · Cited by 20
Metadata
- Authors
- Merle, U., Fein, E., Gehrke, S. G., Stremmel, W., & Kulaksiz, H.
- Affiliations
- University Hospital Heidelberg (DE)
- Corresponding author
- Kulaksiz, Hasan
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2007-06
- Volume
- 148
- Issue
- 6
- Pages
- 2663-2668
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2141288027
- Cited by
- 173
- References
- 38
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 11 · 2023: 9 · 2022: 5 · 2021: 10 · 2020: 6 · 2019: 11 · 2018: 9 · 2017: 6 · 2016: 9 · 2015: 10 · 2014: 18 · 2013: 11 · 2012: 10
- FWCI
- 6.42
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsche Forschungsgemeinschaft
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Keywords
- hepcidin, heart, iron homeostasis, hypoxia, inflammation, cardiac iron overload, myocardial ischemia-reperfusion injury, atherosclerosis, intercalated discs, heart disease, turpentine-induced inflammation
- MeSH terms
- Animals, Gene Expression Regulation, Heart Diseases, Inflammation, Iron, Liver, Male, Myocardium, Oxygen, Cell Hypoxia, Rats, Sprague-Dawley, Antimicrobial Cationic Peptides, Rats, Hepcidins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.